Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134163) titled 'Efficacy and safety of targeted biological agents in the treatment of myasthenia gravis: A single-center retrospective study' on Oct. 11.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University
Condition:
Myasthenia gravis
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2025-08-31
Target Sample Size: Observation group:200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=293895
Disclaimer: Curated by HT Syndication....